Treatment library
Loading treatment roster
Preparing current medications, procedures, devices, and historical context.
Treatment library
Preparing current medications, procedures, devices, and historical context.
Another older sympathomimetic used for short-term obesity treatment. It is still part of the prescription landscape, though far less central to current public conversations than GLP-1 brands.
FDA-approved for short-term obesity treatment.
Sympathomimetic appetite suppression
Varies, but generic cash-pay cost is often relatively modest.
Sympathomimetic appetite suppression
Another older sympathomimetic used for short-term obesity treatment. It is still part of the prescription landscape, though far less central to current public conversations than GLP-1 brands.
medication
current
1959
generic phendimetrazine
phendimetrazine
Multiple generic manufacturers
Yes.
phendimetrazine
Typically lower-cost than branded obesity medications because generic supply exists.
Varies, but generic cash-pay cost is often relatively modest.
Relevant mainly as an older short-term stimulant option rather than a mainstream long-term obesity therapy.
Phendimetrazine remains part of the historical and still-available stimulant family in obesity treatment.
Cardiovascular, sleep, psychiatric, and dependence-related concerns all matter.
dry mouth, restlessness, insomnia, elevated blood pressure, palpitations
Sympathomimetic appetite suppression
Oral immediate-release or extended-release formulations used short term.
Oral tablet or capsule.
These are the official or reference sources used to anchor this treatment profile.
Treatment availability, dosing, cash pricing, and insurance coverage change often. Verify current details with your clinician, pharmacist, surgeon, device program, and insurer before starting, switching, or paying for treatment.